真针灸对比假针灸或等待对照对早期乳腺癌患者芳香化酶抑制剂相关关节痛的影响:一项随机临床试验
该随机临床试验纳入226例服用芳香化酶抑制剂且关节痛评分≥3的绝经后早期乳腺癌患者,按2:1:1分为真针灸组、假针灸组和等待对照组。6周时真针灸组疼痛评分较假针灸组和等待对照组分别多降低0.92分和0.96分,差异有统计学意义,但改善的临床重要性不确定。
要点
- 真针灸较假针灸或等待对照可显著降低芳香化酶抑制剂相关关节痛。
- 6周时真针灸组疼痛评分较假针灸组多降低0.92分(95%CI 0.20-1.65)。
- 真针灸组1级瘀斑发生率高于假针灸组(47% vs 25%)。
核心结论
- 在绝经后早期乳腺癌伴芳香化酶抑制剂相关关节痛患者中,真针灸对比假针灸或等待对照在6周时显著降低关节疼痛,但改善的临床重要性不确定。
研究设计与样本
- 随机临床试验,在美国11个学术中心和临床站点开展,2012年3月至2017年2月,最终随访日期2017年9月5日。
- 纳入226例绝经后早期乳腺癌患者,正在服用芳香化酶抑制剂且简明疼痛量表最痛项(BPI-WP)评分至少3分(评分范围0-10,越高越痛)。
- 按2:1:1随机分为真针灸组(n=110)、假针灸组(n=59)和等待对照组(n=57)。
- 真针灸和假针灸方案均为6周内12次针灸(每周2次),随后每周1次共6周;等待对照组不接受干预;所有参与者在第24至52周间可接受10次针灸。
主要发现
- 从基线到6周,真针灸组BPI-WP评分平均下降2.05分,假针灸组下降1.07分,等待对照组下降0.99分。
关键数值与推荐
- 主要终点为6周时BPI-WP评分,采用线性回归比较各组,校正基线疼痛和分层因素,临床有意义差异预设为2分。
- 226例随机患者平均年龄60.7岁(SD 8.6),88%为白人,基线BPI-WP平均评分6.6(SD 1.5),206例(91.1%)完成试验。
临床怎么用
- 对于服用芳香化酶抑制剂并出现关节痛的绝经后早期乳腺癌患者,真针灸可作为减轻关节疼痛的一种选择,但需注意改善幅度较小且临床意义不确定。
- 针灸治疗可能引起瘀斑等轻微不良反应,临床决策时应结合患者偏好和风险收益。
局限性
- 观察到的疼痛改善幅度低于预设的临床有意义差异(2分),临床重要性不确定。
- 研究人群以白人为主(88%),结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Musculoskeletal symptoms are the most common adverse effects of aromatase inhibitors and often result in therapy discontinuation. Small studies suggest that acupuncture may decrease aromatase inhibitor-related joint symptoms. OBJECTIVE: To determine the effect of acupuncture in reducing aromatase inhibitor-related joint pain. DESIGN, SETTING, AND PATIENTS: Randomized clinical trial conducted at 11 academic centers and clinical sites in the United States from March 2012 to February 2017 (final date of follow-up, September 5, 2017). Eligible patients were postmenopausal women with early-stage breast cancer who were taking an aromatase inhibitor and scored at least 3 on the Brief Pain Inventory Worst Pain (BPI-WP) item (score range, 0-10; higher scores indicate greater pain). INTERVENTIONS: Patients were randomized 2:1:1 to the true acupuncture (n = 110), sham acupuncture (n = 59), or waitlist control (n = 57) group. True acupuncture and sham acupuncture protocols consisted of 12 acupuncture sessions over 6 weeks (2 sessions per week), followed by 1 session per week for 6 weeks. The waitlist control group did not receive any intervention. All participants were offered 10 acupuncture sessions to be used between weeks 24 and 52. MAIN OUTCOMES AND MEASURES: The primary end point was the 6-week BPI-WP score. Mean 6-week BPI-WP scores were compared by study group using linear regression, adjusted for baseline pain and stratification factors (clinically meaningful difference specified as 2 points). RESULTS: Among 226 randomized patients (mean [SD] age, 60.7 [8.6] years; 88% white; mean [SD] baseline BPI-WP score, 6.6 [1.5]), 206 (91.1%) completed the trial. From baseline to 6 weeks, the mean observed BPI-WP score decreased by 2.05 points (reduced pain) in the true acupuncture group, by 1.07 points in the sham acupuncture group, and by 0.99 points in the waitlist control group. The adjusted difference for true acupuncture vs sham acupuncture was 0.92 points (95% CI, 0.20-1.65; P = .01) and for true acupuncture vs waitlist control was 0.96 points (95% CI, 0.24-1.67; P = .01). Patients in the true acupuncture group experienced more grade 1 bruising compared with patients in the sham acupuncture group (47% vs 25%; P = .01). CONCLUSIONS AND RELEVANCE: Among postmenopausal women with early-stage breast cancer and aromatase inhibitor-related arthralgias, true acupuncture compared with sham acupuncture or with waitlist control resulted in a statistically significant reduction in joint pain at 6 weeks, although the observed improvement was of uncertain clinical importance. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01535066.
引用
- Hershman DL, Unger JM, Greenlee H, et al. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial. JAMA. 2018. PMID: 29998338. doi:10.1001/jama.2018.8907
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。